Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
1 other identifier
interventional
142
1 country
1
Brief Summary
To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development. The aims of this study are :
- Assess the caries risk in childhood cancer survivors compared with a control group.
- Assess the dental development defects risk in childhood cancer survivors compared with a control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2024
CompletedFirst Submitted
Initial submission to the registry
July 18, 2024
CompletedFirst Posted
Study publicly available on registry
July 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2026
CompletedNovember 19, 2024
November 1, 2024
2 years
July 18, 2024
November 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of the caries experience by using the Decay Missing Filled Teeth score (DMFT)
Assess the impact of the chemotherapy agents on the risk of ulterior caries development
Thoughout the entire study, approximately during 2 years
Secondary Outcomes (1)
Assessment of the prevalence of dental development defects (DDD)
Thoughout the entire study, approximately during 2 years
Study Arms (2)
Cancer survivor
EXPERIMENTALControl
ACTIVE COMPARATORInterventions
complete clinical oral examination + intra-oral and panoramic x-rays
Eligibility Criteria
You may qualify if:
- age below 10 at cancer diagnosis (for the CCS group).
- Chemotherapy must have been used to treat the patient (For the CCS group).
- The patient is 12 years old or older at the time of the follow-up appointment of the present study
You may not qualify if:
- A patient who was diagnosed and treated after 10 years old.
- Patient below 12 years old at time of study recruitment
- Patients with syndrome or diseases that involve teeth impairment\*
- Pregnant patient
- Refusal or inaptitude to undergo dental and radiographic examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maëlle De Ville de Goyet
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2024
First Posted
July 24, 2024
Study Start
May 3, 2024
Primary Completion
May 3, 2026
Study Completion
May 3, 2026
Last Updated
November 19, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share